FDA Tissue Registration Rule Clarifies Classification Of Combination Devices
This article was originally published in The Gray Sheet
Executive Summary
Manufacturers of combination devices incorporating human cells or tissues will have until Jan. 19, 2003 to register with FDA, according to a final rule released by the agency Jan. 18.
You may also be interested in...
Tissue Bank Regs Fall Under Increased Senate Govt. Affairs Panel Scrutiny
FDA is being asked to provide Senate Governmental Affairs Committee Chair Susan Collins (R-Maine) with all documentation pertaining to the agency's delayed tissue regulations by Sept. 12
Tissue Bank Regs Fall Under Increased Senate Govt. Affairs Panel Scrutiny
FDA is being asked to provide Senate Governmental Affairs Committee Chair Susan Collins (R-Maine) with all documentation pertaining to the agency's delayed tissue regulations by Sept. 12
Tissue Donor Suitability Criteria To Precede GTPs Under Revised FDA Plan
FDA will revise its plans for new risk-based tissue rulemaking by implementing donor suitability and good tissue practice (GTP) final rules concurrently, the agency says. However, the donor suitability final rule will be published first